ЎЗБЕКИСТОНДА ЮМШОҚ ТЎҚИМА САРКОМАЛАРИ БИЛАН КАСАЛЛАНГАН БЕМОРЛАРНИНГ ЎРТАЧА ЁШ КЎРСАТКИЧЛАРИНИ БАҲОЛАШ
Abstract
Долзарблиги: Тиббиѐт тараққиѐти инсоният тараққиѐтига чамбарчас боғлик равишда ривожланиб келаѐтганлигига қарамай кўплаб тиббий муаммолар ўз ечимини кутмоқда. Ана шундай долзарб муаммолардан бири юмшоқ тўқималар саркомаси (ЮТС) хасталигидир.
References
АДАБИЁТЛАР РЎЙҲАТИ:
Nicolazzo C., Gradilone A. Significance of circulating tumor cells in soft tissue sarcoma. Anal Cell Pathol. 2015;
Fletcher CDM, Bridge J.A., Hogendoorn PCW, Mertens F., editors. WHO Lyon, IARC Press. 2013. Classification of tumours of soft tissue and bone. 4th edition.
Hoefkens F., Dehandschutter C., Somville J., Meijnders P., Van Gestel D. Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy. Radiat Oncol. 2016; 11:136. 10.1186/s13014- 016-0668-9
Mehren M., Randall R.L., Benjamin R.S., Boles S., Bui M.M., Ganjoo K.N., George S., Gonzalez R.J., Heslin M.J., Kane J.M. 3rd, Keedy V., Kim E., Koon H., et al.. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. //J Natl Compr Canc Netw. 2018; 16:536–63. 10.6004/jnccn.2018.0025
Honoré C., Méeus P., Stoeckle E., Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg. 2015; 152:223–30. 10.1016/j.jviscsurg.2015.05.
Fletcher CDM. WHO Classification of Tumours of Soft Tissue and Bone. World Health Organization; 2013;
Chibon F., Aurias A., Coindre J.M. Cancer Genomics. Dordrecht: Springer Netherlands; 2013. Sarcomas Genetics: From Point Mutation to Complex Karyotype, from Diagnosis to Therapies; pp. 429–52.
Fletcher CDM, Bridge J.A., Hogendoorn PCW, Mertens F., editors. WHO Lyon, IARC Press. 2013. Classification of tumours of soft tissue and bone. 4th edition.
National Comprehensive Cancer Network Soft Tissue Sarcoma. (ver. 2.2019). 2019.
Jemal A., Siegel R., Ward E., Murray T., Xu J. and Thun MJ: Cancer statistics, 2007. CA Cancer J Cli. 57:43–66. 2007.
Fernebro J., Bladström A., Rydholm A., Gustafson P, Olsson H, Engellau J and Nilbert M: Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients. Br J Cancer. 95:986–990. 2006.
Billingsley K.G., Lewis J.J., Leung D.H., Casper E.S., Woodruff J.M. and Brennan M.F: Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer. 85:389–395. 1999.
Gronchi A., Casali P.G., Mariani L., Miceli R., Fiore M., Lo Vullo S., Bertulli R., Collini P., Lozza L., Olmi P., et al: Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution. J Clin Oncol. 23:96–104. 2005.
Kim H.S., Nam C.M., Jang S-Y, Choi S.K., Han M., Kim S., Moneta M.V., Lee S.Y., Cho J.M., Novick D., Rha S.Y.. Characteristics and treatment patterns of patients with advanced soft tissue sarcoma in iKorea. Cancer Research And Treatment: Official Journal of Korean Cancer Association. 2019;51:1380–1391.
Bessen T., Caughey G.E., Shakib S., Potter J.A., Reid J., Farshid G., Roder D., Neuhaus S.J. A population-based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases. Cancer Epidemiol. 2019; 63:101590.
Italiano A., Mathoulin-Pelissier S., Cesne A.L., Terrier P., Bonvalot S., Collin F., Michels J-J., Blay J-Y., Coindre JM., Bui B. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer. 2011;117:1049–1054.
